Ranking of these genes shows 15 main genetic mechanisms driving efficacy: Genetic contributions identified included leptin, dopamine, glutamate, PI3K-AKT, and histamine mediated signaling as well as other mechanisms Modulating motivation and rewards-based feeding, appetite regulation (positive and negative), energy balance, and glucose homeostasis Drivers of strong responses to GLP-1A drugs were also associated with insulin secretion, lipid metabolism, type-II diabetes risk, cardiac function, fatty acid oxidation, adipocyte differentiation, and obesity The biomarkers were identified in 100% of the patients
Methods: This was a prospective single-center pilot programme in Prince of Wales Hospital, Hong Kong from February 2020 to December 2022
Consult your doctor before use, especially if pregnant, nursing, or managing health conditions
For a detailed comparison of semaglutide versus tirzepatide beyond side effects, including efficacy, dosing, and weight loss data, our dedicated comparison page covers the full picture
Contact Rift Phone/Text: 646-439-5550 Email: [email protected]